Position in NBIX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,237,211
+$1,001,175 QoQ
Shares Held
31,074
+4.0% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
1.90%
of 13F equity value
Holder Rank
#205
of 768 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Advisors Preferred, LLC holds $5,582,057 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (93.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
31,074 | $5,237,211 | |
| 2 | HLN |
Haleon plc
|
36,961 | $344,846 |
All Filings in NBIX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,237,211 | 31,074 | Shares | Other | 2026-08-11 | |
| 2025-12-31 | $4,236,036 | 29,867 | Shares | Other | 2026-02-02 | |
| No filing history on record for this holder in this stock. | ||||||